Hana Biosciences - (HNAB)

Hana Biosciences, Inc. (Nasdaq: HNAB) is a San Francisco, CA-based biopharmaceutical company that acquires, develops, and commercializes innovative products to advance cancer care.  By collaborating with academia and research institutions, Hana identifies development stage product candidates that address unmet oncological needs.  Under the direction an experienced biopharmaceutical management team, Hana moves these unique product candidates through translational research for timely transfer from the lab to clinical development.  The Company has multiple technologies with well-validated mechanisms of action and strong intellectual property rights that provide a platform for accelerated financial growth.
 
Hana completed a reverse merger with a public shell on the American Stock Exchange in 2004 and was listed on the Nasdaq National Market in April 2006.